开窗EVAR中腹腔干整合:支架、无支架开窗与扇形凹槽的中期结局
单中心回顾性研究纳入2007–2024年129例使用定制Zenith开窗支架行FEVAR并整合腹腔干的患者,按支架开窗、无支架开窗或扇形凹槽分组。三组在手术效率、内脏血管通畅性、瘤囊行为、内漏及二次干预率上均无显著差异,支持解剖驱动的个体化选择。
要点
- 三种腹腔干整合策略的手术时间、透视时间、辐射剂量、对比剂用量及估计失血量均无显著差异。
- 随访期内内漏发生率相似(P=0.48),以II型为主,任一策略均无I型或III型内漏增多。
- 腹腔干通畅性丧失及二次干预率在三组间均无显著差异,支持个体化选择。
核心结论
- 支架开窗、无支架开窗与扇形凹槽三种腹腔干整合策略在手术效率、内脏血管耐久性、瘤囊行为及二次干预率方面相当。
- 研究结果支持在FEVAR中采用解剖驱动的个体化腹腔干管理策略,且不损害中期结局。
研究设计与样本
- 回顾性单中心研究,纳入2007–2024年连续接受FEVAR并整合腹腔干的患者,仅使用定制Zenith开窗支架。
- 共129例患者,分为支架开窗组58例、无支架开窗组26例、扇形凹槽组45例,中位随访23.4个月(IQR 9.6–59.4)。
主要发现
- 手术时间、透视时间、辐射剂量、对比剂用量及估计失血量在三组间均无显著差异(所有P>0.05)。
- 随访期间共30例死亡(23.3%),调整随访时间后组间生存无显著差异(P=0.12);30天死亡率低于2%。
- 随访期内漏发生率组间相似(P=0.48),以II型为主,任一策略均无I型或III型内漏增多。
- 瘤囊行为相当,瘤囊直径变化及≥5 mm回缩率无显著差异;腹腔干通畅性丧失及腹腔干相关再干预少见且组间无差异。
- 总体二次干预率在三组间相似(P=0.77)。
临床怎么用
- 在FEVAR中整合腹腔干时,可根据解剖条件个体化选择支架开窗、无支架开窗或扇形凹槽,无需默认某一策略。
- 三种策略的中期内脏血管通畅性和再干预率相当,选择时应优先考虑解剖适配性而非策略本身。
局限性
- 回顾性单中心设计,样本量有限且分组非随机,可能存在选择偏倚。
- 中位随访23.4个月,缺乏更长期耐久性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Incorporation of the celiac axis (CA) during fenestrated endovascular aneurysm repair (FEVAR) can be achieved using stented fenestrations, unstented fenestrations, or scallop configurations. Comparative evidence supporting one strategy over another remains limited. This study aimed to evaluate procedural efficiency, visceral-vessel durability, aneurysm sac behavior, endoleak incidence, and secondary intervention rates across these three CA management strategies. METHODS: A retrospective single-center study was conducted of consecutive patients undergoing FEVAR with CA incorporation between 2007 and 2024 using only custom-made Zenith Fenestrated devices. Patients were grouped according to CA configuration: stented fenestration, unstented fenestration, or scallop. Peri-operative metrics, mortality, endoleaks, CA patency, aneurysm sac evolution, and secondary interventions were analyzed. Between-group comparisons were performed using appropriate nonparametric or categorical statistical tests. RESULTS: A total of 129 patients were included (58 stented, 26 unstented, 45 scallop), with a median follow-up of 23.4 months [IQR 9.6-59.4]. Baseline demographics and comorbidity profiles were comparable. Operative time, fluoroscopy time, radiation dose, contrast volume, and estimated blood loss did not differ significantly between CA strategies (all P > 0.05). Thirty deaths (23.3%) occurred during follow-up, with no significant survival difference between groups after adjustment for follow-up duration (P = 0.12); 30-day mortality remained below 2%. Endoleak incidence during follow-up was similar across strategies (P = 0.48), predominantly type II, with no excess of type I or III endoleaks in any configuration. Aneurysm sac behavior was comparable, with no significant difference in sac diameter change or rates of ≥5 mm regression. Loss of CA patency and CA-related re-interventions were uncommon and did not differ between groups. Overall secondary intervention rates were similar across CA strategies (P = 0.77). CONCLUSION: In this large single-center FEVAR cohort, CA incorporation using stented fenestrations, unstented fenestrations, or scallops resulted in comparable procedural efficiency, visceral-vessel durability, aneurysm sac behavior, and re-intervention rates. These findings support an anatomy-driven, individualized approach to CA management during FEVAR without compromising mid-term outcomes.
引用
- Abdelmalak M, Nadama HH, Rooney K, et al. Procedural and Mid-term Outcomes of Stented, Unstented Fenestrations and Scallop Configurations for Celiac Axis Incorporation in Fenestrated Endovascular Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2026. PMID: 42276362. doi:10.1016/j.avsg.2026.05.099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。